Upsher-Smith Launches Fluvoxamine Maleate Tablets

Upsher-Smith Laboratories, LLC (Upsher-Smith) has announced the launch of fluvoxamine maleate tablets in 25 mg, 50 mg and 100 mg strengths. The fluvoxamine tablet market had U.S. sales of approximately $28 million for the 12 months ending September 2019, according to IQVIA.

Reference

Upsher-Smith Launches Fluvoxamine Maleate Tablets. PR Newswire. Published January 10, 2020. https://www.prnewswire.com/news-releases/upsher-smith-launches-fluvoxamine-maleate-tablets-300984779.html. Accessed January 14, 2020.